Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEVETIRACETAM Cause Disease progression? 247 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 247 reports of Disease progression have been filed in association with LEVETIRACETAM (Levetiracetam). This represents 0.4% of all adverse event reports for LEVETIRACETAM.

247
Reports of Disease progression with LEVETIRACETAM
0.4%
of all LEVETIRACETAM reports
66
Deaths
128
Hospitalizations

How Dangerous Is Disease progression From LEVETIRACETAM?

Of the 247 reports, 66 (26.7%) resulted in death, 128 (51.8%) required hospitalization, and 22 (8.9%) were considered life-threatening.

Is Disease progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEVETIRACETAM. However, 247 reports have been filed with the FAERS database.

What Other Side Effects Does LEVETIRACETAM Cause?

Seizure (9,961) Drug ineffective (8,666) Off label use (5,789) Maternal exposure during pregnancy (3,197) Foetal exposure during pregnancy (2,604) Epilepsy (2,546) Generalised tonic-clonic seizure (2,276) Somnolence (2,070) Fatigue (1,972) Status epilepticus (1,883)

What Other Drugs Cause Disease progression?

RITUXIMAB (7,282) CYCLOPHOSPHAMIDE (7,100) DOXORUBICIN (6,165) VINCRISTINE (5,252) PREDNISONE (5,096) BEVACIZUMAB (4,653) DEXAMETHASONE (4,545) CARBOPLATIN (4,538) CAPECITABINE (3,808) ETOPOSIDE (3,776)

Which LEVETIRACETAM Alternatives Have Lower Disease progression Risk?

LEVETIRACETAM vs LEVOBUNOLOL LEVETIRACETAM vs LEVOBUPIVACAINE LEVETIRACETAM vs LEVOCARNITINE LEVETIRACETAM vs LEVOCETIRIZINE LEVETIRACETAM vs LEVODOPA

Related Pages

LEVETIRACETAM Full Profile All Disease progression Reports All Drugs Causing Disease progression LEVETIRACETAM Demographics